Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesEvaluating the impact of age and disease on survival of chronic lymphocytic leukaemia patients by a new method
International Journal of Clinical Practice, 10/12/09
Klepfish A et al. – Chronic lymphocytic leukaemia had a more unfavourable presentation and a more severe clinical course in the younger patients. This method of evaluating the negative impact of disease on expected survival reveals that their survival also is significantly more affected than that of older patients. The authors suggest calculating the loss of expected survival as a new criterion for assessing disease impact.
Related Articles
Outcomes for lymphoid malignancies in the Nurses Health Study (NHS) as compared to the Surveillance, Epidemiology and End Results (SEER) Program
Hematological Oncology, 11/02/09
Relevance Score: 66%
Effect of allopurinol versus urate oxidase on methotrexate pharmacokinetics in children with newly diagnosed acute lymphoblastic leukemia
Cancer, 10/26/09
Relevance Score: 65%
Detection of early precursors of t(12;21) positive pediatric acute lymphoblastic leukemia during follow-up
Pediatric Blood & Cancer, 10/23/09
Relevance Score: 65%
Frequency of TPMT alleles in Indian patients with acute lymphatic leukemia and effect on the dose of 6-mercaptopurine
Medical Oncology, 10/23/09
Relevance Score: 65%
Role of allogeneic hematopoietic cell transplantation in adults with acute lymphoblastic leukemia
Current Opinion in Oncology, 10/14/09
Relevance Score: 65%
Today in Leukemia/Lymphoma...keeping you current
Receive free subspecialty "5-minute updates" via email
Nonpegylated liposomal doxorubicin (MyocetTM) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): Results from the phase II EUR018 trial
Annals of Oncology, 12/15/09
The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkins lymphoma
European Journal of Haematology, 12/15/09
Long-term follow-up of the United Kingdom medical research council protocols for childhood acute lymphoblastic leukaemia, 1980–2001
Leukemia, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor